# A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

> **NCT06977581** · PHASE2 · RECRUITING · sponsor: **Pfizer** · enrollment: 252 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** PF-07275315
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06977581
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-20
- **Primary completion:** 2027-03-08
- **Final completion:** 2027-05-31
- **Target enrollment:** 252 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06977581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06977581, "A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06977581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*